Osciflex LLC

Osciflex LLC, based in Philadelphia, PA, is dedicated to developing innovative technologies aimed at tackling venous disease through molecular insights. With a focus on preventing hospital-associated venous thromboembolism (HA-VTE), the company addresses a critical healthcare challenge that significantly increases hospital costs and patient morbidity.

Recognizing that 70% of all hospital patients are at risk of VTE, Osciflex is committed to reducing the incidence of this leading cause of preventable hospital deaths in the U.S., which claims approximately 100,000 lives annually and imposes billions in healthcare expenses. Their efforts are aligned with national priorities to enhance patient safety and reduce complications associated with venous diseases.

Generated from the website